ST
AKRO

Skorpios Trust’s Akero Therapeutics AKRO Stock Holding History

Skorpios Trust’s Portfolio AKRO Stock Details AKRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,621,829
Closed -$75.7M – 3
2023
Q2 		$75.7M Sell
1,621,829
-1,650,000
-50% -$75.6M 32.88% 2
2023
Q1 		$125M Hold
3,271,829
– – 50.58% 1
2022
Q4 		$179M Sell
3,271,829
-1,636,000
-33% -$70.1M 57.03% 1
2022
Q3 		$167M Hold
4,907,829
– – 47.17% 2
2022
Q2 		$46.4M Hold
4,907,829
– – 19.41% 2
2022
Q1 		$69.6M Hold
4,907,829
– – 18.54% 2
2021
Q4 		$104M Buy
+4,907,829
New +$109M 22.97% 2

Other funds holding AKRO

Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $22.1B AUM 51.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return